WO2007052274A3 - Magnetic resonance imaging and spectroscopy means and methods thereof - Google Patents
Magnetic resonance imaging and spectroscopy means and methods thereof Download PDFInfo
- Publication number
- WO2007052274A3 WO2007052274A3 PCT/IL2006/001268 IL2006001268W WO2007052274A3 WO 2007052274 A3 WO2007052274 A3 WO 2007052274A3 IL 2006001268 W IL2006001268 W IL 2006001268W WO 2007052274 A3 WO2007052274 A3 WO 2007052274A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- agents
- methods
- metabolic
- magnetic resonance
- resonance imaging
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2006310100A AU2006310100B2 (en) | 2005-11-06 | 2006-11-02 | Magnetic resonance imaging and spectroscopy means and methods thereof |
EP06809828A EP1948248A2 (en) | 2005-11-06 | 2006-11-02 | Magnetic resonance imaging and spectroscopy means and methods thereof |
CA002628608A CA2628608A1 (en) | 2005-11-06 | 2006-11-02 | Magnetic resonance imaging and spectroscopy means and methods thereof |
US12/092,763 US20080287774A1 (en) | 2005-11-06 | 2006-11-02 | Magnetic Resonance Imaging and Spectroscopy Means and Methods Thereof |
JP2008539605A JP2009514946A (en) | 2005-11-06 | 2006-11-02 | Magnetic resonance imaging / spectral means and method thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL171790 | 2005-11-06 | ||
IL17179005 | 2005-11-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007052274A2 WO2007052274A2 (en) | 2007-05-10 |
WO2007052274A3 true WO2007052274A3 (en) | 2009-04-09 |
Family
ID=38006296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2006/001268 WO2007052274A2 (en) | 2005-11-06 | 2006-11-02 | Magnetic resonance imaging and spectroscopy means and methods thereof |
Country Status (6)
Country | Link |
---|---|
US (1) | US20080287774A1 (en) |
EP (1) | EP1948248A2 (en) |
JP (1) | JP2009514946A (en) |
AU (1) | AU2006310100B2 (en) |
CA (1) | CA2628608A1 (en) |
WO (1) | WO2007052274A2 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1954669B1 (en) * | 2005-12-01 | 2015-07-08 | Auspex Pharmaceuticals, Inc. | Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity |
WO2008021891A2 (en) * | 2006-08-08 | 2008-02-21 | Auspex Pharmaceuticals, Inc. | Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
TW200846305A (en) * | 2007-03-15 | 2008-12-01 | Auspex Pharmaceuticals Inc | Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity |
US20110243855A1 (en) * | 2007-08-27 | 2011-10-06 | Anna Gisselsson | Method and imaging medium for use in the method |
US20110008261A1 (en) * | 2008-02-04 | 2011-01-13 | Ge Healthcare Limited | Method to produce hyperpolarised amino acids and aminosulphonic acids |
US20090209550A1 (en) * | 2008-02-20 | 2009-08-20 | Auspex Pharmaceuticals, Inc. | Substituted triazolopyridines |
US8694073B2 (en) * | 2008-10-15 | 2014-04-08 | University Of Utah Research Foundation | Predicting efficacy of psychiatric treatment |
US20100129290A1 (en) * | 2008-11-26 | 2010-05-27 | I.S.T. Corporation | Smart contrast agent and detection method for detecting transition metal ions |
US20100311710A1 (en) * | 2008-12-06 | 2010-12-09 | Auspex Pharmaceuticals, Inc. | Cyclobutanemethanamine inhibitors of monoamine reuptake |
WO2010077730A2 (en) * | 2008-12-09 | 2010-07-08 | Auspex Pharmaceutical, Inc | Indanone inhibitors of acetylcholinesterase |
US9512104B2 (en) | 2009-07-28 | 2016-12-06 | Auspex Pharmaceuticals, Inc. | Quinolone inhibitors of lipoprotein-associated phospholipase A2 |
US8637524B2 (en) | 2009-07-28 | 2014-01-28 | Auspex Pharmaceuticals, Inc | Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 |
US8575348B2 (en) * | 2009-07-28 | 2013-11-05 | Auspex Pharmaceuticals, Inc | Quinolone inhibitors of lipoprotein-associated phospholipase A2 |
WO2011024156A1 (en) | 2009-08-31 | 2011-03-03 | Brain Watch Ltd. | Isotopically labeled neurochemical agents and uses thereof for diagnosing conditions and disorders |
CN102892434B (en) | 2010-04-08 | 2014-11-19 | 伯拉考成像股份公司 | Process for preparing hyperpolarized substrates and method for mri |
WO2012056447A1 (en) * | 2010-10-25 | 2012-05-03 | Brain Watch Ltd. | Isotopically labeled deoxy-glucose and derivatives thereof, compositions comprising them and uses thereof |
EA201390613A1 (en) * | 2010-10-26 | 2013-11-29 | Тева Фармасьютикал Индастриз Лтд. | Enriched by rasagiline deuterium |
US9074237B2 (en) * | 2011-04-13 | 2015-07-07 | Stc.Unm | Method for diagnosing Francisella tularensis infection |
WO2012145733A1 (en) | 2011-04-22 | 2012-10-26 | Vanderbilt University | Para-hydrogen polarizer |
US20140099262A1 (en) * | 2011-06-01 | 2014-04-10 | Brain Watch Ltd. | Isotopically labeled cdp-choline and uses thereof |
US20130017163A1 (en) | 2011-07-14 | 2013-01-17 | Latham Keith R | Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
US10220100B2 (en) | 2011-07-14 | 2019-03-05 | Keith R. Latham | Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
EP2551675A1 (en) * | 2011-07-28 | 2013-01-30 | Chiron AS | Deuterium free, stable isotope labeled 2-phenylethylamine hallucinogens and/or stimulants, methods fo their preparation and their use |
WO2013049112A1 (en) * | 2011-09-27 | 2013-04-04 | Emory University | Detection of biomarkers using magnetic resonance |
US9511154B2 (en) | 2011-10-12 | 2016-12-06 | Bracco Imaging S.P.A. | Process for the preparation of hyperpolarized derivatives for use in MRI analysis |
EP2788035B1 (en) | 2011-12-05 | 2016-03-09 | Bracco Imaging S.p.A | Composition comprising acetic anhydride and a gadolinium complex, and method for the use in hyperpolarisation mri analysis |
EP2833924B1 (en) | 2012-04-02 | 2019-05-08 | Bracco Imaging S.p.A | Hyperpolarized amino acids |
US9329245B2 (en) * | 2012-04-11 | 2016-05-03 | Bruker Biospin Ag | MRI compatible method and device for rapid DNP on a solid state hyperpolarized sample material |
WO2014009240A1 (en) | 2012-07-13 | 2014-01-16 | Bracco Imaging Spa | Triarylmethyl radicals |
PT3261645T (en) | 2015-02-27 | 2021-06-17 | Dechra Ltd | Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats |
WO2019060298A1 (en) | 2017-09-19 | 2019-03-28 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
JP6571149B2 (en) * | 2017-11-20 | 2019-09-04 | 国立大学法人京都大学 | Multiple resonance probe |
US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
EP3731749A4 (en) | 2017-12-31 | 2022-07-27 | Neuroenhancement Lab, LLC | System and method for neuroenhancement to enhance emotional response |
US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
JP7224642B2 (en) * | 2018-07-17 | 2023-02-20 | 学校法人九州文化学園 | Measuring method and measuring device |
CN113382683A (en) | 2018-09-14 | 2021-09-10 | 纽罗因恒思蒙特实验有限责任公司 | System and method for improving sleep |
EP3883612A4 (en) * | 2018-11-21 | 2021-09-29 | The University Of Georgia Research Foundation, Inc. | Bimodal nanoparticle conjugates for non-invasive central nervous system tissue imaging |
JP7111310B2 (en) | 2019-12-11 | 2022-08-02 | 日本電子株式会社 | Nuclear magnetic resonance measurement method and apparatus |
US20220134122A1 (en) * | 2020-11-05 | 2022-05-05 | Bradley Zang | Method of Treatment Using Nuclear Magnetic Photon Excitation |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6617169B2 (en) * | 2001-03-30 | 2003-09-09 | Mclean Hospital Corporation | Two-dimensional MR spectroscopy techniques |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6278893B1 (en) * | 1998-01-05 | 2001-08-21 | Nycomed Imaging As | Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent |
WO2001089584A2 (en) * | 2000-05-23 | 2001-11-29 | Amersham Health As | Contrast agents |
GB0014463D0 (en) * | 2000-06-14 | 2000-08-09 | Nycomed Amersham Plc | NMR Method |
GB0122049D0 (en) * | 2001-09-12 | 2001-10-31 | Nycomed Imaging As | Method |
NO20035626D0 (en) * | 2003-12-17 | 2003-12-17 | Amersham Health As | Method |
-
2006
- 2006-11-02 JP JP2008539605A patent/JP2009514946A/en active Pending
- 2006-11-02 US US12/092,763 patent/US20080287774A1/en not_active Abandoned
- 2006-11-02 AU AU2006310100A patent/AU2006310100B2/en not_active Ceased
- 2006-11-02 CA CA002628608A patent/CA2628608A1/en not_active Abandoned
- 2006-11-02 WO PCT/IL2006/001268 patent/WO2007052274A2/en active Application Filing
- 2006-11-02 EP EP06809828A patent/EP1948248A2/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6617169B2 (en) * | 2001-03-30 | 2003-09-09 | Mclean Hospital Corporation | Two-dimensional MR spectroscopy techniques |
Also Published As
Publication number | Publication date |
---|---|
WO2007052274A2 (en) | 2007-05-10 |
AU2006310100B2 (en) | 2012-12-06 |
EP1948248A2 (en) | 2008-07-30 |
US20080287774A1 (en) | 2008-11-20 |
JP2009514946A (en) | 2009-04-09 |
AU2006310100A2 (en) | 2008-08-07 |
AU2006310100A1 (en) | 2007-05-10 |
CA2628608A1 (en) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007052274A3 (en) | Magnetic resonance imaging and spectroscopy means and methods thereof | |
Angelova et al. | Lipid peroxidation is essential for α‐synuclein‐induced cell death | |
Frazier et al. | Isothermal titration calorimetry study of epicatechin binding to serum albumin | |
GB2433602B (en) | Combined titration and pH electrode for the preparation of liquid samples in particular for NMR spectroscopy | |
WO2010009987A3 (en) | Diagnostic antibody assay | |
WO2008030273A3 (en) | Compositions and methods for diagnosis and treatment of type 2 diabetes | |
WO2007044867A3 (en) | Imaging agents and methods of use thereof | |
EP1908041A4 (en) | Local intercept methods, such as applications for providing customer assistance for training, information calls and diagnostics | |
WO2005084390A3 (en) | Partially loaded antibodies and methods of their conjugation | |
EA200701500A1 (en) | METHODS OF OBTAINING PYRAZOLO [3,4-d] Pyrimidine esters | |
NO20083153L (en) | Chemical connections | |
WO2006036173A3 (en) | Frizzled proteins and detection and treatment of cancer | |
SG155931A1 (en) | Wnt proteins and detection and treatment of cancer | |
BRPI0606481A2 (en) | vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide | |
WO2006034328A3 (en) | Wnt proteins and detection and treatment of cancer | |
ATE542914T1 (en) | PRODUCTION OF HIGHLY ISOTOPICALLY LABELED SECONDARY MICROBIAL METABOLIC METABOLIC PRODUCTS AND CORRESPONDING METABOLISM PRODUCTS | |
GB0718957D0 (en) | Optical imaging agents | |
Xiao et al. | Local unfolding of fatty acid binding protein to allow ligand entry for binding | |
ATE443529T1 (en) | CONTRAST AGENTS FOR MAGNETIC RESONANCE TOMOGRAPHY | |
WO2011051805A8 (en) | Methods and systems for identifying molecules or processes of biological interest by using knowledge discovery in biological data | |
WO2006117166A3 (en) | Mri contrast agents endowed with concentration independent responsiveness | |
WO2006094134A3 (en) | Kim-1 antibodies for treatment of th2-mediated conditions | |
WO2008063779A3 (en) | Cells expressing alpha-synuclein and uses therefor | |
WO2008040882A3 (en) | Method of diagnosing neuropsychiatric diseases, eating disorders or metabolic diseases | |
WO2008014296A3 (en) | Composition and method for treatment of tumors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2628608 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2008539605 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12092763 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006809828 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006310100 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2006310100 Country of ref document: AU Date of ref document: 20061102 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2006310100 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006809828 Country of ref document: EP |